Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Zebrafish ; 11(4): 365-70, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24979594

ABSTRACT

To evaluate the protector effect of ascorbic acid (AA) against anxiogenic-like effect induced by methylmercury (MeHg) exposure, adult zebrafish were treated with AA (2 mg g(-1), intraperitoneal [i.p.]) before MeHg administration (1.0 µg g(-1), i.p.). Groups were tested for the light/dark preference as a behavioral model of anxiety, and the content of serotonin and its oxidized metabolite tryptamine-4,5-dione (T-4,5-D) in the brain was determined by high-performance liquid chromatography. MeHg has produced a marked anxiogenic profile in both tests, and this effect was accompanied by a decrease in the extracellular levels of serotonin, and an increase in the extracellular levels of T-4,5-D. Added to this, a marked increase in the formation of a marker of oxidative stress accompanied these parameters. Interestingly, the anxiogenic-like effect and biochemical alterations induced by MeHg were blocked by pretreatment with AA. These results for the first time demonstrated the potential protector action of AA in neurobehavioral and neurochemical alterations induced by methylmecury exposure demonstrating that zebrafish model could be used as an important tool for testing substances with neuroprotector actions.


Subject(s)
Antioxidants/pharmacology , Anxiety/chemically induced , Ascorbic Acid/pharmacology , Brain/drug effects , Environmental Pollutants/toxicity , Methylmercury Compounds/toxicity , Zebrafish/metabolism , Animals , Brain/metabolism , Chromatography, High Pressure Liquid , Indolequinones/metabolism , Serotonin/metabolism , Tryptamines/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...